Tel Aviv University researchers have advanced the 2015 research by Hebrew University scientists (see here previously) and isolated the specific neutrophils that support cancer progression. It boosts the development of new therapies and adds a biomarker for early detection of the disease.
https://emergexint.tau.ac.il/neutrophil_immune_cancer_research